References
- New Brunswick Government. Commission of Inquiry into Pathology Services at the Miramichi Regional Health Authority, http://www.miramichicommission.ca/en/about_inq.php (accessed 4 June 2009)
- Cameron M A. Newfoundland Commission of Inquiry on Hormone Receptor Testing, http://www.cihrt.nl.ca (accessed 4 June 2009)
- Cancer Committee, College of American Pathologists. An Overview of the College of American Pathologists Cancer Checklists, 2009, http://www.cap.org/apps/docs/committees/cancer/cancer_protocols/Overview_CAP_Cancer_Checlkists_090115.pdf (accessed 4 June 2009)
- Lester S C, Shikha B, Chen Y Y, et al. Protocol for the examination of specimens from patients with ductal carcinoma in situ of the breast. Arch Pathol Lab Med 2009; 133: 15–25
- Liévre A, Bachet J B, Boige V, et al. KRAS mutations as an independent prognostic factor in patients with advanced colorectal cancer treated with Cetuximab. J Clin Oncol 2008; 26: 374–379